$GILD “Newton said the shares could see an additional boost given the company is at the forefront of coronavirus treatment testing. China began a clinical trial of Gilead’s antiviral treatment remdesivir in the country last week. “I like Gilead and I would own it and look to buy any weakness,” said Newton.” cnbc.com/2020/02/11/gilead-...
  • 4
  • 1